-
Cy7 NHS Ester: Practical Protein Labeling Guide
2026-09-16
Cy7 NHS ester (SKU A8109) provides a water-soluble, sulfonated near-infrared labeling option for proteins and peptides containing accessible amino groups. It is appropriate for controlled biomolecule conjugation and near-infrared imaging workflows, but the reagent should not be stored as a solution long term or treated as a universal label for targets lacking suitable primary amines.
-
LY-411575: Gamma-Secretase Inhibitor Workflow
2026-09-15
LY-411575 enables controlled inhibition of amyloid beta production while simultaneously exposing Notch pathway effects in cell and translational models. This practical guide connects dose-response design, synaptic-function assays, and troubleshooting for Alzheimer’s disease research and exploratory cancer research.
-
TCEP hydrochloride for Capture-and-Release LFAs
2026-09-15
TCEP hydrochloride offers a water-soluble, thiol-free route for reducing cleavable disulfide linkers in capture-and-release lateral flow workflows. Used after complex capture and washing, it can help translate high-affinity rebinding concepts into a controlled assay-development strategy while preserving compatibility with protein and analytical workflows.
-
Metal-Chelating l-Phe Nanostructures Sensitize Tumors
2026-09-14
A Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can reverse key features of an immunosuppressive tumor microenvironment and improve immune checkpoint blockade responses. Its mechanistic advance is the integration of short-term starvation, ion-channel regulation, dendritic-cell activation, and tumor-specific cytotoxic T-cell responses.
-
Cytochalasin B: Actin Assay Workflows
2026-09-14
Cytochalasin B (NSC 107658) provides a reversible way to perturb actin-dependent motility, division, uptake, and transport while preserving time-resolved experimental control. This guide turns that mechanism into practical dose-finding, imaging, functional, and cytotoxicity workflows with troubleshooting strategies for cleaner interpretation.
-
ASB3 Suppresses Antiviral Immunity via MAVS
2026-09-13
The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ubiquitin ligase that weakens antiviral innate immunity by directing MAVS toward K48-linked ubiquitination and proteasomal degradation. Its cellular and animal experiments connect ASB3 activity with reduced interferon signaling and increased influenza susceptibility, while providing a mechanistic framework for studying regulation of RIG-I-like receptor pathways.
-
ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors
2026-09-12
The reference study shows that ATRX-deficient high-grade glioma cells are more vulnerable to several multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. Its combination data with temozolomide support ATRX status as a useful biomarker for interpreting RTK-inhibitor responses in glioma research, while also highlighting the need for genotype-stratified validation.
-
TNF-alpha recombinant murine protein Assay Guide
2026-09-11
Build more interpretable apoptosis and inflammation experiments with a defined, high-potency murine cytokine and a workflow that separates TNF receptor signaling from transcription-associated death. This guide covers reconstitution, dose finding, orthogonal controls, and troubleshooting for reproducible cell culture cytokine treatment.
-
Vorinostat and mRNA Lipoplex Protein Expression
2026-09-11
Tang and Hattori investigated whether the HDAC inhibitor vorinostat could increase protein production after mRNA lipoplex administration, extending a mechanism traditionally associated with DNA transgene expression into an mRNA delivery setting. The study found cell-dependent enhancement in vitro but limited improvement in vivo, emphasizing that reporter expression, tissue distribution, dose, and formulation must be interpreted together.
-
N3-kethoxal: Reading Nucleic Acid Accessibility
2026-09-10
N3-kethoxal converts exposed guanines in RNA and single-stranded DNA into clickable structural records. This guide explains how to design, interpret, and control guanine-selective chemical probing workflows using insights from ribosomal footprinting research.
-
EdU Imaging in Pulmonary Vascular Remodeling
2026-09-10
How precise S-phase DNA synthesis measurement can strengthen mechanistic and translational studies of the STAT1/MMP8/DRP1 axis in pulmonary hypertension.
-
FAST Nanoparticles for Food-Grade Nutraceutical Delivery
2026-09-09
The reference study evaluates Facilitated Self-Assembling Technology (FAST) as a surfactant-free, food-grade route for producing stable nanoparticles from poorly soluble nutraceuticals. Its hybrid formulations improved surface charge, size distribution, and simulated gastric stability while retaining cellular compatibility, although in vivo bioavailability was not established.
-
KG-501 in Macrophage–Tumor Signaling Assays
2026-09-09
KG-501 is a mechanistic probe for CREB–CBP KIX disruption and transcriptional network analysis. This article explains how to interpret its use in macrophage–tumor signaling studies, including the practical assay lessons from Jiedu Xiaozheng Yin research in colitis-associated colorectal cancer.
-
EdU Imaging Kits (Cy5): Practical Protocol Guide
2026-09-08
EdU Imaging Kits (Cy5) provide a practical endpoint assay for detecting DNA synthesis during S-phase in fixed-cell microscopy and flow cytometry workflows. They are suitable for cell proliferation and genotoxicity assessment when paired with appropriate controls, but EdU signal alone should not be treated as a complete measure of viability, cell-cycle distribution, or treatment mechanism.
-
Ultrasound-Triggered Piezo-Nanoplatforms for Epilepsy
2026-09-08
This study develops a biomimetic piezoelectric nanoplatform that converts externally applied ultrasound into localized electrical stimulation for non-invasive suppression of epileptic activity. By combining neuromodulation with sustained antiepileptic drug delivery, the platform offers a dual-treatment strategy intended to reduce dependence on implanted electrodes and limit systemic drug exposure.